Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleDecreased hospital charges and postoperative pain in septoplasty by application of enhanced recovery after surgery
dc.contributor.authorLiao, Z.
dc.contributor.authorLiao, W.
dc.contributor.authorTan, K.S.
dc.contributor.authorSun, Y.
dc.contributor.authorPeng, A.
dc.contributor.authorZhu, Y.
dc.contributor.authorHe, H.
dc.contributor.authorYang, S.
dc.contributor.authorXu, G.
dc.contributor.authorSu, R.
dc.contributor.authorYao, J.
dc.contributor.authorFan, Y.
dc.contributor.authorYang, Q.
dc.contributor.authorHong, H.
dc.identifier.citationLiao, Z., Liao, W., Tan, K.S., Sun, Y., Peng, A., Zhu, Y., He, H., Yang, S., Xu, G., Su, R., Yao, J., Fan, Y., Yang, Q., Hong, H. (2018). Decreased hospital charges and postoperative pain in septoplasty by application of enhanced recovery after surgery. Therapeutics and Clinical Risk Management 14 : 1871-1877. ScholarBank@NUS Repository.
dc.description.abstractObjective: Septoplasty has been the definitive treatment for nasal septum deviation, but its postoperative procedure may affect patients’ quality of life. While new procedures in general surgery, such as enhanced recovery after surgery (ERAS), can speed up postoperative reha-bilitations to improve quality of life, it is rarely applied in the ear–nose–throat field. This study therefore aims to evaluate the application of ERAS in patients with nasal septum deviation as a means of improving perioperative outcomes. Materials and methods: Fifty patients with nasal septum deviation undergoing septoplasty were randomized as ERAS or control group (25 patients in both groups). Patients were investigated for outcomes including length of stay, operating time, bleeding volume, total cost, complications, and Self-Rating Anxiety Scale (SAS) and visual analog symptom score of nasal obstruction, sleep disturbance, and head facial pain. Results: The preoperative anxiety in ERAS group (SAS 35.4±6.2) was lower than the control group (SAS 43.6±8.6). The anxiety levels in ERAS group (SAS 31.6±5.4) was also reduced compared to the control group (SAS 38.1±10.4) in the 3 days postsurgery, but showed no significant difference thereafter at 7 days postsurgery. In addition, the length of stay and total cost were significantly lower for the ERAS group as well. The visual analog symptom score of nasal obstruction, sleep disturbance, and head facial pain in ERAS group were all also found to be lower than the control group. The only outcomes with no significant differences were the operation time, blood volume, and complications between the groups. Conclusion: Our study indicated ERAS application can reduce hospital charges and postoperative pain in septoplasty, thereby improving patient quality of life and hospital expenses at the same time. © 2018 Liao et al.
dc.publisherDove Medical Press Ltd.
dc.rightsAttribution-NonCommercial 4.0 International
dc.sourceScopus OA2018
dc.subjectEnhanced recovery after surgery
dc.subjectHospital charges
dc.subjectNasal septum deviation
dc.subjectPostoperative pain
dc.description.sourcetitleTherapeutics and Clinical Risk Management
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_2147_TCRM_S173687.pdf1.89 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons